• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.12% Nasdaq Up 0.71%

    More On SKP.L

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    Skyepharma PLC (SKP.L)

    -LSE
    320.50 Up 2.75(0.87%) Apr 24, 11:35AM EDT
    Add to Portfolio
    Prev Close:317.75
    Open:307.00
    Bid:320.25
    Ask:320.75
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:307.00 - 321.75
    52wk Range:223.00 - 379.19
    Volume:84,107
    Avg Vol (3m):204,568
    Market Cap:335.64M
    P/E (ttm):N/A
    EPS (ttm):-0.18
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in GBp.

    Headlines

    • No Headlines available for SKP.L at this time.

    Key Statistics

    Forward P/E (1 yr):0.16
    P/S (ttm):301.96
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :19.67
    Quarterly EPS Est (0-00-31) :N/A
    Mean Recommendation*:1.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Skyepharma PLC develops and sells oral and inhalation pharmaceutical products. The company’s inhalation products include flutiform, a multi-dose pressurized metered dose inhaler for the treatment of bronchial asthma; Anoro Ellipta and Incruse... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback